44 results on '"van Putten, Wim L.J."'
Search Results
2. Risk stratification of intermediate-risk acute myeloid leukemia: integrative analysis of a multitude of gene mutation and gene expression markers
3. Dose Escalation and Quality of Life in Patients With Localized Prostate Cancer Treated With Radiotherapy: Long-Term Results of the Dutch Randomized Dose-Escalation Trial (CKTO 96-10 Trial)
4. Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial
5. Postoperative radiotherapy for Stage 1 endometrial carcinoma: Long-term outcome of the randomized PORTEC trial with central pathology review
6. Acute and late complications after radiotherapy for prostate cancer: Results of a multicenter randomized trial comparing 68 Gy to 78 Gy
7. Dose-Response in Radiotherapy for Localized Prostate Cancer: Results of the Dutch Multicenter Randomized Phase III Trial Comparing 68 Gy of Radiotherapy With 78 Gy
8. Prognostic Index for Adult Patients With Acute Myeloid Leukemia in First Relapse
9. Outcome of High-Risk Stage IC, Grade 3, Compared With Stage I Endometrial Carcinoma Patients: The Postoperative Radiation Therapy in Endometrial Carcinoma Trial
10. Breast Cancer after Prophylactic Bilateral Mastectomy in Women with a BRCA1 or BRCA2 Mutation
11. Survival after relapse in patients with endometrial cancer: results from a randomized trial☆
12. Bone Marrow Transplantation versus Chemotherapy in Non-Hodgkin's Lymphoma
13. The morbidity of treatment for patients with stage I endometrial cancer: results from a randomized trial
14. Autonomous Proliferation Of Leukemic Cells In Vitro As A Determinant Of Prognosis In Adult Acute Myeloid Leukemia
15. Acute morbidity reduction using 3DCRT for prostate carcinoma: a randomized study
16. Comparison of the clinical effectiveness of the 433 MHz lucite cone applicator with that of a conventional waveguide applicator in applications of superficial hyperthermia
17. Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome
18. The impact of abn(17p) and monosomy −5/del(5q) on the prognostic value of the monosomal karyotype in acute myeloid leukemia
19. Update of Dutch Multicenter Dose-Escalation Trial of Radiotherapy for Localized Prostate Cancer
20. Sexual Function After Three-Dimensional Conformal Radiotherapy for Prostate Cancer: Results From a Dose-Escalation Trial
21. Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients.
22. Cytogenetic clonality analysis of megakaryocytes in myelodysplastic syndrome by dual-color fluorescence in situ hybridization and confocal laser scanning microscopy.
23. Prognostic value of CD44 variant expression in primary breast cancer.
24. DNA-synthesis enzyme activity: A biological tool useful for predicting anti-metabolic drug sensitivity in breast cancer?
25. Clinical Useful Prognostic Index for Adult Patients with Acute Myeloid Leukemia in First Relapse.
26. Daunorubicin and Cytarabine Compared with Daunorubicin, Cytarabine and the MDR1 Reversal Agent PSC-833 in Elderly Patients with Acute Myelogenous Leukemia.
27. Muscle invasive bladder cancer treated by transurethral resection, followed by external beam radiation and interstitial iridium-192
28. Maximum likelihood estimation for Luce's choice model
29. The prognostic value of epidermal growth factor receptors, determined by both immunohistochemistry and ligand binding assays, in primary epithelial ovarian cancer: a pilot study
30. Comparison of four filters for leukocyte depletion of single donor plateletapheresis products
31. Biopsy of nonpalpable cervical lymph nodes: Selection criteria for ultrasound-guided biopsy in patients with head and neck squamous cell carcinoma
32. Mitomycin C is an inactive drug in the third-line treatment of hormone and chemotherapy refractory breast cancer
33. Bone Marrow Transplantation versus Chemotherapy in Non-Hodgkin's Lymphoma.
34. Comparison of CHOP Chemotherapy with Autologous Bone Marrow Transplantation for Slowly Responding Patients with Aggressive Non-Hodgkin's Lymphoma.
35. Anaplastic carcinoma of the thyroid gland treated by radiation therapy
36. Dose–Volume Parameters of the Corpora Cavernosa Do Not Correlate With Erectile Dysfunction After External Beam Radiotherapy for Prostate Cancer: Results From a Dose–Escalation Trial
37. Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer
38. 143 Muscle invasive bladder cancer treated by transurethral resection, followed by external beam radiation and interstitial iridium-192
39. Cancer of the supraglottic larynx without clinically detectable lymph node metastases (T1–4NO) — the problem of local control, neck relapse and overall treatment time -
40. Reirradiation of Recurrent Tumors in the Head and Neck
41. Dose, fractionation and overall treatment time in radiation therapy—The effects on local control for cancer of the larynx
42. Comment on a proposed test of the fit of the linear-quadratic model to radiation isoeffect data
43. Prognosis and cytomorphometry in breast cancer
44. Heterogeneous X Inactivation in Trophoblastic Cells of Human Full-Term Female Placentas.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.